The majority of Directors of Investor Relations at ECLINICALWORKS, LLC believe they're not compensated fairly. 33% of Directors of Investor Relations at ECLINICALWORKS, LLC say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at ECLINICALWORKS, LLC